Skip to main content
. 2024 Jun 15;11(7):ofae309. doi: 10.1093/ofid/ofae309

Table 2.

Predictors of Receipt of Fecal Microbiota Transplantation in Clostridioides difficile Infection Episodes Among Patients With ≥1 Recurrence and Hospitalization

Predictor Patients by Receipt of FMT After CDI Episode, No. (%) OR (95% CI)
No FMT (n = 3902) FMT Received (n = 150)
Demographic characteristics
 Race
  White 1737 (45) 90 (60) Reference
  Black 1444 (37) 34 (23) 0.19 (.08–.46)
  Other 52 (1.3) 3 (2) 1.25 (.09–18.60)
  Unknown 669 (17) 23 (15) 0.42 (.15–1.19)
 Sex
  Female 2292 (59) 109 (72) Reference
  Male 1610 (41) 41 (27) 0.55 (.39–.78)
 Age category
  18–44 y 641 (16) 37 (25) Reference
  45–64 y 1258 (33) 50 (33) 0.40 (.16–1.02)
  65–79 y 1272 (33) 37 (25) 0.22 (.08–.60)
  ≥80 y 721 (18) 26 (17) 0.35 (.11–1.07)
Comorbid conditions
 Peripheral vascular disease 488 (13) 13 (9) 0.67 (.38–1.17)
 Cerebrovascular disease 703 (18) 11 (7) 0.35 (.19–.65)
 Dementia 531 (14) 12 (8) 0.56 (.31–1.00)
 Chronic pulmonary disease 1106 (28) 41 (27) 0.98 (.69–1.39)
 Congestive heart failure 1739 (45) 44 (29) 0.55 (.39–.77)
 Rheumatoid disease 220 (6) 10 (7) 1.24 (.68–2.26)
 Peptic ulcer disease 336 (8.6) 10 (7) 0.77 (.41–1.44)
 Mild liver disease 487 (12) 10 (7) 0.51 (.27–.97)
 Diabetes 1363 (35) 34 (23) 0.54 (.37–.79)
 Diabetes with complications 1229 (32) 23 (15) 0.41 (.27–.64)
 Hemiplegia or paraplegia 283 (7) 6 (4) 0.53 (.23–1.19)
 Renal disease 1749 (45) 37 (25) 0.42 (.29–.6)
 Cancer 698 (18) 21 (14) 0.78 (.50–1.22)
 Moderate to severe liver disease 165 (4.2) 1 (0.7) 0.14 (.02–1.0)
 HIV 163 (4) 4 (3) 0.75 (.31–1.78)
 Inflammatory bowel disease 48 (1) 1 (0.01) 0.52 (.03–2.5)
 Dialysis 318 (4) 6 (4) 0.47 (.18–.98)
CDI episode
 2 2442 (63) 53 (35) Reference
 3 806 (21) 55 (37) 13.9 (5.66–34.14)
 4 326 (8) 30 (20) 26.7 (9.06–78.81)
 5 156 (4) 5 (3) 2.25 (.24–20.65)
 >5 172 (4) 7 (5) 3.32 (.50–22.00)

Abbreviations: CDI, Clostridioides difficile infection; CI, confidence interval; FMT, fecal microbiota transplantation; HIV, human immunodeficiency virus; OR, odds ratio.